Last updated on November 2018

Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy


Brief description of study

The overall aim of this trial, which is called STAMPEDE, is to assess novel approaches for the treatment of men with prostate cancer who are starting long-term ADT for the first time, termed hormone-nave prostate cancer. This trial aims to see if we can improve the way in which prostate cancer is currently managed, either by adding new treatments to the standard approach or by modifying the type of hormone therapy aiming to improve quality-of-life by reducing the side effects of treatment. Each new treatment approach is compared against a control arm receiving the current standard treatments. We aim to identify treatment strategies that enable men to live longer, or as long but with an improved quality-of-life, as well as offering value for money for the health service.

Since opening to accrual in Oct-2005, the trial has tested many ways of treating prostate cancer and some results are now already known. More than 10,000 men will join the trial with answers becoming available throughout the trial. New patients joining the trial from Protocol version 17.0 onwards (activated in December 2018) may be eligible to join one of two treatment comparisons, metformin (treatment group K; the "metformin comparison") and transdermal oestradiol (treatment group L; the "transdermal oestradiol comparison"). A computer program will be used to allocate which treatment each participant receives, using a chance process.

Summary of the research arms in STAMPEDE trial platform Summary of research treatment groups currently open to recruitment (June 2017)

  1. Metformin (Arm K): This anti-diabetic medication is proposed to have both anti-cancer effects and may help prevent the adverse metabolic effects of long-term ADT. STAMPEDE will investigate whether adding metformin to the current standard-of-care for non-diabetic men can improve all-cause survival.
  2. Transdermal oestradiol (Arm L): This is an alternative form of hormone treatment which has been shown to suppress testosterone as effectively as standard ADT and avoid some of the side-effects. It may also help to avoid the adverse metabolic effects and fatigue and therefore improve overall quality of life compared with standard forms of ADT. STAMPEDE will investigate whether transdermal oestradiol can treat the cancer as well as current standard forms of ADT.
  3. Control group (Arm A): Patients allocated to this group receive the current standard-of-care ADT +/- RT +/- docetaxel.

Detailed Study Description

STAMPEDE (also known as MRC PR08) is a multi-arm multi-stage (MAMS) randomised controlled trial recruiting in the UK and Switzerland. It aims to evaluate multiple therapeutic strategies in the management of high-risk locally advanced and metastatic hormone-nave prostate cancer. Each novel treatment strategy is compared against a single, contemporaneous control arm. When the trial originally opened in 2005 there were 6 research arms enabling 5 randomised comparisons. Each comparison is evaluated in stages with pre-planned interim analyses after which recruitment may be halted should the experimental treatment fail to reach a "hurdle" of activity. Patient data from all arms and all stages are, however, included in the final analyses of the primary outcome measure, even if the investigational arm did not proceed to the final stage.

Providing sufficient activity is demonstrated, recruitment continues to the final stage and then an assessment of efficacy is determined based on the primary outcome of overall survival. Patient data from all arms and all stages are included in the final analyses of the primary outcome measure, even if the investigational arm did not proceed to the final stage.

The original comparisons which have all now been reported, evaluated a bisphosphonate (zoledronic acid), a cytotoxic chemotherapeutic agent (docetaxel) and a cyclooxygenase (Cox 2) inhibitor (celecoxib), as single agents or combinations. Since the start of the trial, a number of new research arms have been added to STAMPEDE over time to evaluate: abiraterone, a steroid synthesis inhibitor; prostate radiotherapy for patients with newly diagnosed metastatic disease; enzalutamide, an inhibitor of androgen receptor signalling, given with abiraterone; and metformin, an anti-diabetic medication and transdermal oestradiol, to be given as an alternative form of ADT.

Objectives

Primary

To compare the safety and efficacy of novel therapeutic strategies against the current standard-of-care for men with high-risk locally advanced or metastatic prostate cancer starting long-term ADT for the first time.

Outline: This is a randomised, controlled, multi-centre MAMS trial platform. Patients are current randomised to 1 of 3 arms: control group (arm A), metformin treatment group (arm K) and transdermal oestradiol (Arm L). The other arms are all closed to recruitment with results known for all the original comparisons and awaited for others added since the trial commenced.

Patient population: STAMPEDE recruits both men with high-risk locally advanced prostate cancer and men with metastatic prostate cancer, all of whom must be starting long-term ADT for the first time. Patients who received previous radical treatment and are now relapsing with high-risk features are also eligible.

Follow-up: All patients are follow-up life long

Sub-studies: There are several translational sub-studies ongoing as part of STAMPEDE. Participation is optional. These currently include several translational sub-studies involving sample collection: saliva collection for germline DNA analysis, sequential circulating tumour DNA analysis and FFPE tumour block retrieval for DNA and RNA analysis. Other sub-studies include a QOL sub-study and an imaging sub-study.

Clinical Study Identifier: NCT00268476

Find a site near you

Start Over

Liestal Hospital

Liestal, Switzerland
  Connect »

Winterthur Hospital

Winterthur, Switzerland
  Connect »

William Harvey Hospital

Ashford, United Kingdom
  Connect »

Stoke Mandeville Hospital

Aylesbury, United Kingdom
  Connect »

City Hospital (Birmingham)

Birmingham, United Kingdom
  Connect »

Royal Bournemouth Hospital

Bournemouth, United Kingdom
  Connect »

Bradford Royal Infirmary

Bradford, United Kingdom
  Connect »

Broomfield Hospital

Broomfield, United Kingdom
  Connect »

Burnley General Hospital

Burnley, United Kingdom
  Connect »

Queen's Hospital

Burton-upon-Trent, United Kingdom
  Connect »

West Suffolk Hospital

Bury St. Edmunds, United Kingdom
  Connect »

Kent and Canterbury Hospital

Canterbury, United Kingdom
  Connect »

Cumberland Infirmary

Carlisle, United Kingdom
  Connect »

Cheltenham General Hospital

Cheltenham, United Kingdom
  Connect »

Castle Hill Hospital

Cottingham, United Kingdom
  Connect »

Darlington Memorial

Darlington, United Kingdom
  Connect »

Doncaster Royal Infirmary

Doncaster, United Kingdom
  Connect »

Dorset County Hospital

Dorchester, United Kingdom
  Connect »

Russells Hall Hospital

Dudley, United Kingdom
  Connect »

Royal Bolton Hospital

Farnworth, United Kingdom
  Connect »

Wycombe General Hospital

High Wycombe, United Kingdom
  Connect »

Ipswich Hospital

Ipswich, United Kingdom
  Connect »

Kidderminster Hospital

Kidderminster, United Kingdom
  Connect »

Glenfield Hospital

Leicester, United Kingdom
  Connect »

University Hospital Aintree

Liverpool, United Kingdom
  Connect »

UCL Cancer Institute

London, United Kingdom
  Connect »

Charing Cross Hospital

London, United Kingdom
  Connect »

Guy's Hospital

London, United Kingdom
  Connect »

St. George's Hospital

London, United Kingdom
  Connect »

St. Mary's Hospital

London, United Kingdom
  Connect »

Withington Hospital

Manchester, United Kingdom
  Connect »

Christie Hospital

Manchester, United Kingdom
  Connect »

James Cook University Hospital

Middlesbrough, United Kingdom
  Connect »

Nottingham City Hospital

Nottingham, United Kingdom
  Connect »

Royal Oldham Hospital

Oldham, United Kingdom
  Connect »

Churchill Hospital

Oxford, United Kingdom
  Connect »

Queen's Hospital

Romford, United Kingdom
  Connect »

Conquest Hospital

Saint Leonards-on-Sea, United Kingdom
  Connect »

Scarborough General Hospital

Scarborough, United Kingdom
  Connect »

Royal Shrewsbury Hospital

Shrewsbury, United Kingdom
  Connect »

South Tyneside District Hospital

South Shields, United Kingdom
  Connect »

Southampton General Hospital

Southampton, United Kingdom
  Connect »

Lister Hospital

Stevenage, United Kingdom
  Connect »

Stepping Hill Hospital

Stockport, United Kingdom
  Connect »

Sunderland Royal Hospital

Sunderland, United Kingdom
  Connect »

King's Mill Hospital

Sutton-in-Ashfield, United Kingdom
  Connect »

Great Western Hospital

Swindon, United Kingdom
  Connect »

Musgrove Park Hospital

Taunton, United Kingdom
  Connect »

Torbay Hospital

Torquay, United Kingdom
  Connect »

Weston General Hospital

Weston Super Mare, United Kingdom
  Connect »

West Cumberland Hospital

Whitehaven, United Kingdom
  Connect »

Worcester Royal Hospital

Worcester, United Kingdom
  Connect »

Worthing Hospital

Worthing, United Kingdom
  Connect »

St. Mary's Hospital

Newport, United Kingdom
  Connect »

Ayr Hospital

Ayr, United Kingdom
  Connect »

Raigmore Hospital

Inverness, United Kingdom
  Connect »

Bronglais General Hospital

Aberystwyth, United Kingdom
  Connect »

Addenbrooke's Hospital

Cambridge, United Kingdom
  Connect »

Forth Valley Hospital

Larbert, United Kingdom
  Connect »

Lincoln Hospital

Lincoln, United Kingdom
  Connect »

Freeman Hospital

Newcastle, United Kingdom
  Connect »

North Tees Hospital

Stockton-on-Tees, United Kingdom
  Connect »

New Cross Hospital

Wolverhampton, United Kingdom
  Connect »

Inselspital Bern

Berne, Switzerland
  Connect »

Poole Hospital

Poole, United Kingdom
  Connect »

Hereford County Hospital

Hereford, United Kingdom
  Connect »

Royal Stoke University Hospital

Stoke-on-Trent, United Kingdom
  Connect »

Royal Marsden - Sutton

Sutton, United Kingdom
  Connect »

Good Hope Hospital

Sutton Coldfield, United Kingdom
  Connect »

Huddersfield Royal Infirmary

Huddersfield, United Kingdom
  Connect »

Colchester General Hospital

Colchester, United Kingdom
  Connect »